TRADING QUOTES CLICK ON A TAB BELOW: (Business Combination or IPO Details) to access the relevant details. Additional info below. PROPOSED BUSINESS COMBINATION: Gemini Therapeutics ESTIMATED CURRENT FUNDS in TRUST: $120.8 million*CURRENT PER SHARE REDEMPTION PRICE: $10.00*EQUITY VALUE: $465 million *SPACInsider estimate a/o 11-14-20 Gemini Therapeutics, a clinical stage precision Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.
